维普中文期刊产品整合服务
51篇 您的检索式:作者名="Bitzan"
    题名 作者 年代 出处 被引量
1Treatment of typical(erteropathic) hemolytic uremic syndrome显示文摘Bitzan M Schaefer F Reymond D 2010Semin Thromb Hemost2010,36,6:1
2Rituximab ( B - cell depleting antibody) associated lung injury( RALI):A pediatric case and systematic review of the literature 显示文摘Bitzan M Anselmo M Carpineta L 2009Pediatr Pulmonol2009,44,9:1
3The Structure of Railroad Costs and the Benefits/Cosls of Mergers显示文摘Bitzan John D 1999Research in Transportation Economics1999,5,:1
4Railroad Costs and Competition: The Implications of Introducing Competition to Railroad Networks 显示文摘Bitzan John D 2003Journal of Transport Economics and Policy2003,37,2:1
5Recurrence of curetted and bone grafted giant cell tumors with and without adjuvant phenol therapy显示文摘Trieb K Bitzan P Lang S 2001EJ SO2001,27,2:1
6Treatment of typical (enteropathic) hemolytic uremic syndrome显示文摘Bitzan M Schaefer F Reymond D 2010Semin Thromb Hemost2010,36,6:1
7Cryptogenic organizing pneumoniaafter rituximab therapy for presumed post-kidney transplant lymphopro-liferative disease 显示文摘Bitzan M Ouahed JD Carpineta L 2010Pediatr Nephrol2010,25,6:1
8Treatment options for HUS secondary to Escherichia coli O157:H7显示文摘Bitzan M 2009Kidney Int Suppl2009,112,:1
9Non-enteropath- ic hemolytic uremic syndrome: causes and short- term course显示文摘Constantinescu AR Bitzan M Weiss LS 2004Am J Kidney Dis2004,43,6:1
10Immune response to non-O157 Vero toxin-producing Escherichia coli in patients with he molyticuremic syndrome显示文摘Ludwig K Bitzan M Zimmermann S 1996J Infect Dis1996,174,:1
11Serum cobalt levels after metal-on-metal total hip arthroplasty 显示文摘Brodner W Bitzan P Meisinger V 2003J Bone Joint Surg Am2003,11,:1
12Six-year results of a cementless stem with prophylaxis against heterotopic bone 显示文摘Wurnig C Schwameis E Bitzan P 1999Clin Orthop Relat Res1999,,361:1
13Serum cobalt levels after metal-on-metal total hip arthroplasty显示文摘Brodner W Bitzan P Meisinger V 0,,11:1
14Immune response to non-O157 Vero toxin-producing Escherichia coli in patients with he molyticuremic syndrome显示文摘Ludwig K Bitzan M Zimmermann S 1996J Infect Dis1996,174,:1
15Rituximab (B-cell depleting antibody) associated lung injury(RALI):a pediatric case and systematic review of the literature显示文摘Bitzan M Anselmo M Carpineta L 0,,09:1
16Management of hemolytic uremic syndrome显示文摘Loirat C Saland J Bitzan M 2012Presse Med2012,41,32:1
17Rituximab (B-cell depleting antibody) associated lung injury (RALI):a pediatric case and systematic review of the literature显示文摘Bitzan M Anselmo M Carpineta L 2009Pediatr Pulmonol2009,44,:1
18Serum cobalt and serum chromium level in 2 patients with chronic renal failure after total hip prosthesis implantation with metal-metal gliding contact显示文摘Brodner W Grohs JG Bitzan P 2000Z Orthop Ihre Grertzgeb2000,138,:1
19Rituximab(B-cell depleting antibody) associated lung injury(RALI)a pediatric case and systematic review of the literature显示文摘Bitzan M Anselmo M Carpineta L 2009Pediatr Pulmonol2009,44,9:1
20Analysis of genes encoding laminin β2 and related proteins in patients with Galloway-Mowat syndrome显示文摘Dietrich A Matejas V Bitzan M 2008Pediatr Nephrol2008,23,:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费